Wednesday, May 21, 2025
spot_img

Prospect Capital Corporation Announces Redemption of its 3.706% Notes due 2026

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect,” “our” or “we”) announced today that it will redeem all outstanding 3.706% Notes due 2026 (the “Notes”) at a price of 100% of the principal amount of the Notes to be redeemed, plus accrued but unpaid interest, to but excluding the Redemption Date (the “Redemption Price”). The redemption date will be June 18, 2025 (the “Redemption Date”).

The Notes are held through The Depository Trust Company and will be redeemed in accordance with the applicable procedures.

This press release does not constitute a notice of redemption under the indenture governing the Notes.

About Prospect Capital Corporation
Prospect is a business development company lending to and investing in private businesses. Prospect’s investment objective is to generate both current income and long-term capital appreciation through debt and equity investments.

Prospect has elected to be treated as a business development company under the Investment Company Act of 1940. Prospect elected to be treated as a regulated investment company under the Internal Revenue Code of 1986.

Caution Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, whose safe harbor for forward-looking statements does not apply to business development companies. Any such statements, other than statements of historical fact, are highly likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under our control, and that we may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from any forward-looking statements. Such statements speak only as of the time when made, and we undertake no obligation to update any such statement now or in the future.

For additional information, contact:

Grier Eliasek, President and Chief Operating Officer
[email protected]
Telephone (212) 448-0702

Powered by SlickText.com

Hot this week

IDEX Biometrics ASA: Annual general meeting held on 21 May 2025

IDEX Biometrics ASA held the annual general meeting on...

Silexion Therapeutics Completes Key Preclinical Studies Exploring SIL204’s Potential Impact on Colorectal and Lung Cancer

Silexion’s new groundbreaking study explores the potential impact of...

AITX Expands in $50B Security Market as AI Replaces the Security Staff

Company Scales Deployment of Voice-Interactive Devices, Targeting Operational Profitability...

ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update

Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement...

Topics

IDEX Biometrics ASA: Annual general meeting held on 21 May 2025

IDEX Biometrics ASA held the annual general meeting on...

AITX Expands in $50B Security Market as AI Replaces the Security Staff

Company Scales Deployment of Voice-Interactive Devices, Targeting Operational Profitability...

DIGITAL ALLY, INC. ANNOUNCES FIRST QUARTER OPERATING RESULTS

COMPANY REPORTS EARNINGS PER SHARE OF $1.41, COMPARED WITH...

Blüm Holdings Expands Platform Through the Contemplated Acquisition of Cookies Equity Holder

Strategic transaction will deepen Blüm's indirect stake in Cookies...
spot_img

Related Articles

Popular Categories

spot_img